| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.607 | 0.004 | 0.826 | Platelet adhesion inhibitor | 0.351 0.019 CHEMBL3526245 0.356 0.018 CHEMBL3526247 0.826 0.002 CHEMBL3526246 0.451 0.008 CHEMBL3527031 0.291 0.037 CHEMBL3542353 | CHEMBL3526246 | |
| 0.552 | 0.009 | 0.552 | Anticonvulsant | 0.189 0.091 CHEMBL3526245 0.249 0.058 CHEMBL3526247 0.227 0.067 CHEMBL3542353 | ||
| 0.476 | 0.056 | 0.476 | Analgesic | 0.31 0.134 CHEMBL3526247 0.37 0.098 CHEMBL3527031 0.372 0.097 CHEMBL3542353 | ||
| 0.454 | 0.048 | 0.886 | Antiobesity | 0.524 0.033 CHEMBL3526247 0.368 0.079 CHEMBL3526246 0.886 0.005 CHEMBL3527031 0.603 0.02 CHEMBL3542353 | CHEMBL3527031 | |
| 0.418 | 0.024 | 0.956 | Platelet antagonist | 0.519 0.012 CHEMBL3526245 0.38 0.031 CHEMBL3526247 0.956 0.002 CHEMBL3526246 0.261 0.068 CHEMBL3527031 0.281 0.059 CHEMBL3542353 | CHEMBL3526246 | |
| 0.399 | 0.049 | 0.64 | Antithrombotic | 0.317 0.078 CHEMBL3526245 0.223 0.151 CHEMBL3526247 0.64 0.012 CHEMBL3526246 0.357 0.062 CHEMBL3542353 | CHEMBL3526246 | |
| 0.345 | 0.007 | 0.362 | Alpha 2b adrenoreceptor antagonist | 0.101 0.074 CHEMBL3526245 0.175 0.03 CHEMBL3526247 0.362 0.006 CHEMBL3527031 0.103 0.072 CHEMBL3542353 0.093 0.082 CHEMBL3526248 | CHEMBL3527031 | |
| 0.285 | 0.006 | 0.44 | Dopamine D1 antagonist | 0.085 0.03 CHEMBL3526245 0.1 0.025 CHEMBL3526247 0.44 0.004 CHEMBL3527031 | CHEMBL3527031 | |
| 0.285 | 0.012 | 0.397 | Dopamine antagonist | 0.156 0.025 CHEMBL3526247 0.397 0.008 CHEMBL3527031 0.11 0.035 CHEMBL3542353 0.09 0.042 CHEMBL3526248 | CHEMBL3527031 | |
| 0.275 | 0.009 | 0.275 | Alpha 2 adrenoreceptor antagonist | 0.086 0.059 CHEMBL3526247 0.198 0.018 CHEMBL3527031 | ||
| 0.28 | 0.018 | 0.28 | 5 Hydroxytryptamine 2 antagonist | 0.164 0.04 CHEMBL3526247 0.251 0.021 CHEMBL3527031 0.1 0.071 CHEMBL3542353 0.156 0.042 CHEMBL3526248 | ||
| 0.294 | 0.037 | 0.906 | Platelet aggregation inhibitor | 0.906 0.003 CHEMBL3526246 | CHEMBL3526246 | |
| 0.252 | 0.009 | 0.329 | Dopamine D4 antagonist | 0.192 0.013 CHEMBL3526247 0.329 0.006 CHEMBL3527031 0.067 0.038 CHEMBL3542353 0.065 0.039 CHEMBL3526248 | CHEMBL3527031 | |
| 0.241 | 0.005 | 0.241 | Purinergic P2 antagonist | 0.11 0.018 CHEMBL3526245 0.171 0.009 CHEMBL3526247 0.058 0.05 CHEMBL3527031 0.187 0.008 CHEMBL3526248 | ||
| 0.311 | 0.082 | 0.311 | Thyroid hormone beta antagonist | |||
| 0.251 | 0.027 | 0.291 | 3C-like protease (Human coronavirus) inhibitor | 0.162 0.083 CHEMBL3526245 0.252 0.027 CHEMBL3526247 0.176 0.068 CHEMBL3527031 0.291 0.013 CHEMBL3526248 | CHEMBL3526248 | |
| 0.231 | 0.013 | 0.231 | Alpha 2c adrenoreceptor antagonist | 0.098 0.067 CHEMBL3526247 0.205 0.017 CHEMBL3527031 0.085 0.082 CHEMBL3542353 | ||
| 0.307 | 0.09 | 0.307 | Thyroid hormone antagonist | |||
| 0.237 | 0.022 | 0.237 | Alpha adrenoreceptor antagonist | 0.079 0.072 CHEMBL3526247 0.209 0.026 CHEMBL3527031 | ||
| 0.224 | 0.015 | 0.362 | Dopamine D2 antagonist | 0.362 0.008 CHEMBL3527031 0.088 0.036 CHEMBL3542353 0.057 0.052 CHEMBL3526248 | CHEMBL3527031 | |
| 0.219 | 0.015 | 0.219 | 5 Hydroxytryptamine 2C antagonist | 0.133 0.031 CHEMBL3526247 0.077 0.064 CHEMBL3542353 0.12 0.036 CHEMBL3526248 | ||
| 0.214 | 0.012 | 0.214 | Alpha 2a adrenoreceptor antagonist | 0.19 0.015 CHEMBL3527031 | ||
| 0.197 | 0.002 | 0.197 | Glucose-6-phosphate translocase inhibitor | 0.091 0.008 CHEMBL3526245 0.188 0.002 CHEMBL3526247 0.177 0.003 CHEMBL3527031 0.083 0.01 CHEMBL3542353 0.087 0.009 CHEMBL3526248 | ||
| 0.218 | 0.03 | 0.218 | 5 Hydroxytryptamine antagonist | 0.133 0.057 CHEMBL3526247 0.132 0.058 CHEMBL3527031 0.124 0.062 CHEMBL3526248 | ||
| 0.193 | 0.02 | 0.201 | 5 Hydroxytryptamine 2A antagonist | 0.118 0.038 CHEMBL3526247 0.201 0.019 CHEMBL3527031 0.116 0.039 CHEMBL3526248 | CHEMBL3527031 | |
| 0.2 | 0.042 | 0.22 | Acetylcholine M1 receptor antagonist | 0.139 0.085 CHEMBL3526245 0.22 0.034 CHEMBL3542353 | CHEMBL3542353 | |
| 0.315 | 0.164 | 0.315 | MAP kinase 1 inhibitor | 0.266 0.216 CHEMBL3526247 | ||
| 0.307 | 0.156 | 0.441 | Cyclophilin D inhibitor | 0.429 0.076 CHEMBL3526247 0.441 0.071 CHEMBL3542353 0.245 0.219 CHEMBL3526248 | CHEMBL3542353 | |
| 0.155 | 0.009 | 0.155 | Dopamine D4 agonist | 0.054 0.031 CHEMBL3526247 0.077 0.02 CHEMBL3542353 | ||
| 0.159 | 0.014 | 0.159 | Dopamine agonist | |||
| 0.231 | 0.088 | 0.231 | Hypoglycemic | 0.214 0.1 CHEMBL3526245 | ||
| 0.16 | 0.022 | 0.16 | Histamine H1 receptor antagonist | 0.131 0.029 CHEMBL3526247 0.074 0.064 CHEMBL3527031 0.138 0.027 CHEMBL3542353 0.085 0.052 CHEMBL3526248 | ||
| 0.15 | 0.015 | 0.225 | Dopamine D3 antagonist | 0.074 0.035 CHEMBL3526247 0.225 0.009 CHEMBL3527031 0.086 0.03 CHEMBL3526248 | CHEMBL3527031 | |
| 0.145 | 0.01 | 0.145 | Alpha 2d adrenoreceptor antagonist | 0.112 0.031 CHEMBL3526245 0.138 0.013 CHEMBL3526247 0.115 0.028 CHEMBL3527031 0.133 0.015 CHEMBL3526248 | ||
| 0.172 | 0.047 | 0.424 | Hemostatic | 0.424 0.006 CHEMBL3526246 0.203 0.031 CHEMBL3527031 | CHEMBL3526246 | |
| 0.13 | 0.012 | 0.13 | 5 Hydroxytryptamine 3 antagonist | 0.125 0.013 CHEMBL3526247 0.051 0.047 CHEMBL3527031 0.103 0.017 CHEMBL3526248 | ||
| 0.246 | 0.129 | 0.246 | Prostaglandin dehydrogenase inhibitor | |||
| 0.192 | 0.077 | 0.193 | 5 Hydroxytryptamine 3E antagonist | 0.188 0.086 CHEMBL3526247 0.164 0.157 CHEMBL3526246 0.193 0.075 CHEMBL3542353 0.176 0.117 CHEMBL3526248 | CHEMBL3542353 | |
| 0.225 | 0.11 | 0.267 | 5 Hydroxytryptamine uptake stimulant | 0.212 0.13 CHEMBL3526245 0.202 0.148 CHEMBL3526247 0.267 0.066 CHEMBL3542353 0.197 0.158 CHEMBL3526248 | CHEMBL3542353 | |
| 0.123 | 0.01 | 0.123 | 5 Hydroxytryptamine 6 antagonist | 0.09 0.018 CHEMBL3526247 0.085 0.02 CHEMBL3526248 | ||
| 0.241 | 0.132 | 0.263 | Cholesterol antagonist | 0.263 0.116 CHEMBL3526245 0.202 0.163 CHEMBL3526247 | CHEMBL3526245 | |
| 0.132 | 0.025 | 0.214 | 5 Hydroxytryptamine agonist | 0.079 0.042 CHEMBL3526247 0.214 0.013 CHEMBL3527031 0.064 0.051 CHEMBL3526248 | CHEMBL3527031 | |
| 0.153 | 0.047 | 0.153 | Pregnane X receptor agonist | 0.147 0.058 CHEMBL3526245 0.15 0.052 CHEMBL3526247 0.141 0.071 CHEMBL3542353 0.151 0.051 CHEMBL3526248 | ||
| 0.119 | 0.014 | 0.128 | Protein kinase C iota inhibitor | 0.128 0.013 CHEMBL3526247 0.067 0.035 CHEMBL3527031 0.098 0.019 CHEMBL3526248 | CHEMBL3526247 | |
| 0.143 | 0.04 | 0.143 | Sphingosine 1-phosphate receptor 4 antagonist | 0.118 0.076 CHEMBL3526245 0.111 0.092 CHEMBL3526247 0.124 0.065 CHEMBL3526248 | ||
| 0.175 | 0.072 | 0.175 | Tumour necrosis factor antagonist | |||
| 0.121 | 0.021 | 0.121 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.107 | 0.008 | 0.145 | Purinergic P2X antagonist | 0.059 0.024 CHEMBL3526245 0.098 0.009 CHEMBL3526247 0.145 0.005 CHEMBL3526248 | CHEMBL3526248 | |
| 0.252 | 0.156 | 0.252 | Beta lactamase inhibitor | |||
| 0.116 | 0.023 | 0.116 | Histamine H2 receptor antagonist | 0.096 0.039 CHEMBL3526247 | ||
| 0.098 | 0.008 | 0.098 | 5 Hydroxytryptamine 2C agonist | 0.088 0.009 CHEMBL3526247 0.057 0.023 CHEMBL3527031 0.053 0.026 CHEMBL3542353 0.064 0.018 CHEMBL3526248 | ||
| 0.109 | 0.022 | 0.109 | Acetylcholine M4 receptor antagonist | 0.076 0.05 CHEMBL3542353 | ||
| 0.103 | 0.018 | 0.103 | Acetylcholine M5 receptor agonist | 0.077 0.037 CHEMBL3526247 0.062 0.052 CHEMBL3542353 | ||
| 0.121 | 0.037 | 0.121 | Nitric-oxide synthase inhibitor | 0.104 0.054 CHEMBL3526247 | ||
| 0.132 | 0.05 | 0.132 | 5 Hydroxytryptamine 2B antagonist | 0.106 0.076 CHEMBL3526247 0.108 0.073 CHEMBL3542353 0.111 0.07 CHEMBL3526248 | ||
| 0.093 | 0.013 | 0.096 | Exportin-1 inhibitor | 0.069 0.044 CHEMBL3526245 0.093 0.013 CHEMBL3526247 0.072 0.038 CHEMBL3527031 0.075 0.033 CHEMBL3542353 0.096 0.011 CHEMBL3526248 | CHEMBL3526248 | |
| 0.123 | 0.044 | 0.123 | Acetylcholine release stimulant | 0.108 0.069 CHEMBL3526247 0.111 0.063 CHEMBL3526248 | ||
| 0.093 | 0.017 | 0.093 | Alpha 2 adrenoreceptor agonist | 0.068 0.033 CHEMBL3526247 | ||
| 0.082 | 0.006 | 0.082 | Purinergic P2T antagonist | 0.021 0.015 CHEMBL3526245 0.021 0.015 CHEMBL3527031 | ||
| 0.092 | 0.019 | 0.092 | 5 Hydroxytryptamine 3 agonist | 0.079 0.028 CHEMBL3526247 0.061 0.047 CHEMBL3526248 | ||
| 0.078 | 0.008 | 0.097 | Urate transporter 1 inhibitor | 0.097 0.005 CHEMBL3526247 0.074 0.009 CHEMBL3526248 | CHEMBL3526247 | |
| 0.128 | 0.06 | 0.159 | Acetylcholine muscarinic antagonist | 0.108 0.081 CHEMBL3526245 0.159 0.039 CHEMBL3542353 | CHEMBL3542353 | |
| 0.089 | 0.022 | 0.089 | Dopamine uptake inhibitor | 0.07 0.03 CHEMBL3526245 0.053 0.045 CHEMBL3526247 0.085 0.023 CHEMBL3542353 0.05 0.049 CHEMBL3526248 | ||
| 0.07 | 0.005 | 0.07 | Nerve growth factor antagonist | 0.042 0.031 CHEMBL3526245 0.065 0.007 CHEMBL3526247 0.041 0.033 CHEMBL3527031 0.056 0.012 CHEMBL3526248 | ||
| 0.093 | 0.03 | 0.093 | Benzodiazepine agonist | 0.063 0.062 CHEMBL3526247 | ||
| 0.099 | 0.037 | 0.372 | CYP2A6 inhibitor | 0.162 0.013 CHEMBL3526247 0.372 0.003 CHEMBL3526248 | CHEMBL3526248 | |
| 0.099 | 0.038 | 0.102 | Inducible nitric-oxide synthase inhibitor | 0.102 0.035 CHEMBL3526247 | CHEMBL3526247 | |
| 0.064 | 0.004 | 0.064 | Integrin alpha1beta1 antagonist | 0.051 0.007 CHEMBL3526245 0.061 0.004 CHEMBL3526247 0.051 0.007 CHEMBL3527031 0.058 0.005 CHEMBL3526248 | ||
| 0.109 | 0.05 | 0.149 | Antiadrenergic | 0.149 0.036 CHEMBL3527031 | CHEMBL3527031 | |
| 0.107 | 0.05 | 0.147 | Adrenaline antagonist | 0.147 0.035 CHEMBL3527031 | CHEMBL3527031 | |
| 0.138 | 0.083 | 0.144 | Sphingosine 1-phosphate receptor 5 antagonist | 0.144 0.073 CHEMBL3542353 | CHEMBL3542353 | |
| 0.249 | 0.193 | 0.249 | DNA polymerase beta inhibitor | |||
| 0.073 | 0.018 | 0.073 | 5 Hydroxytryptamine 2 agonist | 0.066 0.022 CHEMBL3526247 0.052 0.035 CHEMBL3526248 | ||
| 0.093 | 0.038 | 0.106 | Caspase 7 inhibitor | 0.106 0.022 CHEMBL3526247 0.096 0.032 CHEMBL3526248 | CHEMBL3526247 | |
| 0.089 | 0.036 | 0.089 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.079 | 0.027 | 0.079 | Adrenaline uptake inhibitor | 0.057 0.049 CHEMBL3526247 0.054 0.052 CHEMBL3527031 0.056 0.049 CHEMBL3526248 | ||
| 0.107 | 0.056 | 0.107 | Gastric antisecretory | 0.097 0.069 CHEMBL3526248 | ||
| 0.085 | 0.034 | 0.085 | Alpha adrenoreceptor agonist | 0.061 0.055 CHEMBL3526247 | ||
| 0.101 | 0.051 | 0.101 | Potassium channel (Voltage-sensitive) activator | |||
| 0.058 | 0.009 | 0.081 | Phenylethanolamine N methyltransferase inhibitor | 0.041 0.027 CHEMBL3526245 0.081 0.004 CHEMBL3526246 0.046 0.019 CHEMBL3527031 0.039 0.032 CHEMBL3542353 | CHEMBL3526246 | |
| 0.082 | 0.033 | 0.082 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.143 | 0.095 | 0.143 | Heat shock protein 90 alpha antagonist | |||
| 0.092 | 0.043 | 0.092 | Glutamate receptor agonist | |||
| 0.113 | 0.064 | 0.113 | Nav1.5 sodium channel blocker | 0.102 0.082 CHEMBL3526247 0.108 0.071 CHEMBL3526248 | ||
| 0.26 | 0.214 | 0.26 | 5 Hydroxytryptamine release inhibitor | 0.25 0.228 CHEMBL3526245 0.246 0.234 CHEMBL3526248 | ||
| 0.163 | 0.117 | 0.163 | HERG channel blocker | 0.141 0.14 CHEMBL3542353 | ||
| 0.074 | 0.028 | 0.074 | Acetylcholine M5 receptor antagonist | |||
| 0.1 | 0.055 | 0.1 | Antihistaminic | |||
| 0.122 | 0.078 | 0.152 | Antibacterial (Helicobacter pylori) | 0.129 0.069 CHEMBL3526245 0.152 0.044 CHEMBL3526248 | CHEMBL3526248 | |
| 0.053 | 0.01 | 0.053 | Heme oxygenase inhibitor | 0.043 0.03 CHEMBL3526245 0.05 0.013 CHEMBL3526247 0.048 0.016 CHEMBL3526246 0.051 0.012 CHEMBL3542353 0.046 0.021 CHEMBL3526248 | ||
| 0.136 | 0.092 | 0.145 | Heat shock protein 70 antagonist | 0.141 0.073 CHEMBL3526245 0.135 0.095 CHEMBL3526247 0.145 0.057 CHEMBL3526248 | CHEMBL3526248 | |
| 0.282 | 0.239 | 0.282 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.267 0.261 CHEMBL3542353 | ||
| 0.073 | 0.03 | 0.073 | Acetylcholine M3 receptor antagonist | 0.061 0.04 CHEMBL3526245 | ||
| 0.051 | 0.009 | 0.051 | Poly(ADP-ribose) polymerase 2 inhibitor | |||
| 0.108 | 0.067 | 0.115 | 5 Hydroxytryptamine 3A agonist | 0.115 0.06 CHEMBL3526247 | CHEMBL3526247 | |
| 0.054 | 0.014 | 0.054 | TRPM8 blocker | 0.051 0.015 CHEMBL3526247 | ||
| 0.093 | 0.053 | 0.093 | Histamine antagonist | |||
| 0.051 | 0.015 | 0.051 | Acid-sensing ion channel blocker | 0.042 0.026 CHEMBL3526245 | ||
| 0.11 | 0.075 | 0.115 | Cholesterol synthesis inhibitor | 0.115 0.07 CHEMBL3526245 | CHEMBL3526245 | |
| 0.043 | 0.008 | 0.065 | Sodium/glucose cotransporter 2 inhibitor | 0.065 0.005 CHEMBL3526245 0.038 0.009 CHEMBL3526247 0.026 0.019 CHEMBL3527031 0.04 0.008 CHEMBL3526248 | CHEMBL3526245 | |
| 0.044 | 0.011 | 0.044 | Endothelial nitric-oxide synthase inhibitor | 0.034 0.018 CHEMBL3526247 | ||
| 0.065 | 0.033 | 0.065 | Potassium channel intermediate-conductance Ca-activated blocker | 0.055 0.054 CHEMBL3526247 | ||
| 0.063 | 0.031 | 0.123 | Acetylcholine muscarinic agonist | 0.123 0.014 CHEMBL3542353 | CHEMBL3542353 | |
| 0.071 | 0.04 | 0.071 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.083 | 0.053 | 0.083 | CC chemokine 5 receptor agonist | |||
| 0.077 | 0.047 | 0.078 | Vanilloid 4 agonist | 0.078 0.044 CHEMBL3526245 0.071 0.062 CHEMBL3526248 | CHEMBL3526245 | |
| 0.053 | 0.024 | 0.053 | CC chemokine 4 receptor antagonist | 0.046 0.034 CHEMBL3526247 0.052 0.025 CHEMBL3542353 0.045 0.036 CHEMBL3526248 | ||
| 0.045 | 0.017 | 0.048 | Purinergic P2X7 antagonist | 0.043 0.019 CHEMBL3526247 0.048 0.015 CHEMBL3526248 | CHEMBL3526248 | |
| 0.123 | 0.095 | 0.278 | Cell wall synthesis inhibitor | 0.114 0.108 CHEMBL3526245 0.152 0.064 CHEMBL3526247 0.125 0.093 CHEMBL3542353 0.278 0.012 CHEMBL3526248 | CHEMBL3526248 | |
| 0.116 | 0.089 | 0.147 | Sodium channel blocker | 0.147 0.06 CHEMBL3526245 | CHEMBL3526245 | |
| 0.093 | 0.066 | 0.109 | Lanosterol 14 alpha demethylase inhibitor | 0.108 0.044 CHEMBL3526245 0.1 0.056 CHEMBL3526247 0.109 0.043 CHEMBL3542353 0.098 0.059 CHEMBL3526248 | CHEMBL3542353 | |
| 0.076 | 0.049 | 0.076 | Rho-associated kinase II inhibitor | |||
| 0.072 | 0.046 | 0.072 | Amidase inhibitor | |||
| 0.052 | 0.027 | 0.056 | Dopamine beta hydroxylase inhibitor | 0.052 0.027 CHEMBL3526247 0.056 0.02 CHEMBL3526248 | CHEMBL3526248 | |
| 0.074 | 0.05 | 0.074 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.078 | 0.054 | 0.088 | Alpha 1 adrenoreceptor antagonist | 0.088 0.049 CHEMBL3527031 | CHEMBL3527031 | |
| 0.05 | 0.029 | 0.232 | 5 Hydroxytryptamine 1A agonist | 0.232 0.008 CHEMBL3527031 0.077 0.02 CHEMBL3526248 | CHEMBL3527031 | |
| 0.083 | 0.062 | 0.085 | NMDA receptor antagonist | 0.085 0.059 CHEMBL3526247 | CHEMBL3526247 | |
| 0.053 | 0.033 | 0.158 | Prostaglandin E2 antagonist | 0.05 0.035 CHEMBL3526245 0.046 0.039 CHEMBL3526247 0.158 0.008 CHEMBL3526248 | CHEMBL3526248 | |
| 0.031 | 0.01 | 0.044 | Sodium/glucose cotransporter inhibitor | 0.044 0.006 CHEMBL3526245 0.029 0.012 CHEMBL3526247 0.025 0.02 CHEMBL3527031 0.028 0.013 CHEMBL3526248 | CHEMBL3526245 | |
| 0.074 | 0.055 | 0.074 | Analgesic, opioid | 0.067 0.066 CHEMBL3542353 | ||
| 0.032 | 0.013 | 0.032 | LFA antagonist | 0.03 0.016 CHEMBL3526245 | ||
| 0.038 | 0.019 | 0.058 | Purinergic P2X3 antagonist | 0.037 0.019 CHEMBL3526247 0.058 0.009 CHEMBL3526248 | CHEMBL3526248 | |
| 0.055 | 0.037 | 0.124 | CC chemokine 2 receptor antagonist | 0.049 0.047 CHEMBL3526245 0.124 0.009 CHEMBL3542353 | CHEMBL3542353 | |
| 0.05 | 0.033 | 0.05 | Squalene epoxidase inhibitor | 0.047 0.04 CHEMBL3526245 0.046 0.044 CHEMBL3526248 | ||
| 0.027 | 0.01 | 0.027 | ICAM 1 antagonist | 0.021 0.02 CHEMBL3526245 0.025 0.012 CHEMBL3526248 | ||
| 0.081 | 0.064 | 0.091 | Acetylcholine agonist | 0.091 0.054 CHEMBL3542353 | CHEMBL3542353 | |
| 0.026 | 0.011 | 0.028 | Alpha 2d adrenoreceptor agonist | 0.028 0.01 CHEMBL3526247 0.021 0.016 CHEMBL3527031 0.028 0.009 CHEMBL3526248 | CHEMBL3526248 | |
| 0.052 | 0.037 | 0.052 | Dipeptidyl peptidase inhibitor | |||
| 0.051 | 0.037 | 0.051 | Phosphodiesterase 7A inhibitor | 0.051 0.039 CHEMBL3526248 | ||
| 0.049 | 0.034 | 0.052 | CC chemokine receptor 2B antagonist | 0.052 0.027 CHEMBL3526245 | CHEMBL3526245 | |
| 0.044 | 0.029 | 0.114 | Acetylcholine M1 receptor agonist | 0.114 0.011 CHEMBL3542353 | CHEMBL3542353 | |
| 0.045 | 0.031 | 0.045 | Purinergic P2Y antagonist | |||
| 0.041 | 0.03 | 0.043 | CC chemokine 3 receptor antagonist | 0.043 0.028 CHEMBL3542353 | CHEMBL3542353 | |
| 0.039 | 0.029 | 0.039 | Glucagon-like peptide 1 receptor antagonist | 0.037 0.035 CHEMBL3526248 | ||
| 0.057 | 0.047 | 0.057 | Acetylcholine M2 receptor antagonist | 0.054 0.05 CHEMBL3542353 | ||
| 0.052 | 0.043 | 0.072 | Sphingosine kinase 2 inhibitor | 0.072 0.02 CHEMBL3526245 | CHEMBL3526245 | |
| 0.057 | 0.049 | 0.057 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.176 | 0.168 | 0.176 | Neuropeptide Y2 antagonist | |||
| 0.045 | 0.037 | 0.634 | Sigma receptor antagonist | 0.634 0.004 CHEMBL3526246 0.255 0.007 CHEMBL3542353 | CHEMBL3526246 | |
| 0.016 | 0.01 | 0.016 | NMDA receptor phencyclidine site antagonist | |||
| 0.06 | 0.055 | 0.073 | Sphingosine 1-phosphate receptor 4 agonist | 0.073 0.042 CHEMBL3526248 | CHEMBL3526248 | |
| 0.031 | 0.027 | 0.033 | Gonadotropin-releasing hormone receptor antagonist | 0.033 0.025 CHEMBL3526247 | CHEMBL3526247 | |
| 0.048 | 0.043 | 0.048 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.06 | 0.056 | 0.06 | Bcl2 antagonist | |||
| 0.061 | 0.057 | 0.069 | Alpha 1a adrenoreceptor antagonist | 0.069 0.051 CHEMBL3527031 | CHEMBL3527031 | |
| 0.027 | 0.023 | 0.03 | 5 Hydroxytryptamine 6 agonist | 0.03 0.017 CHEMBL3526247 0.028 0.022 CHEMBL3526248 | CHEMBL3526247 | |
| 0.038 | 0.034 | 0.041 | CF transmembrane conductance regulator antagonist | 0.041 0.024 CHEMBL3526245 | CHEMBL3526245 | |
| 0.03 | 0.027 | 0.03 | Vasopressin 2 antagonist | |||
| 0.101 | 0.098 | 0.135 | Sphingosine 1-phosphate receptor 2 agonist | 0.101 0.099 CHEMBL3526247 0.135 0.037 CHEMBL3526248 | CHEMBL3526248 | |
| 0.052 | 0.049 | 0.077 | Prostaglandin EP2 antagonist | 0.077 0.028 CHEMBL3526245 | CHEMBL3526245 | |
| 0.021 | 0.019 | 0.021 | Dopamine D1 agonist | |||
| 0.046 | 0.044 | 0.069 | Prostaglandin antagonist | 0.069 0.027 CHEMBL3526248 | CHEMBL3526248 | |
| 0.162 | 0.161 | 0.162 | Cardiotonic | |||
| 0.025 | 0.027 | 0.043 | Prostaglandin EP3 antagonist | 0.03 0.021 CHEMBL3526245 0.043 0.012 CHEMBL3526248 | CHEMBL3526248 | |
| 0.046 | 0.048 | 0.051 | Antiviral (Hepatitis D) | 0.051 0.034 CHEMBL3526247 0.051 0.035 CHEMBL3542353 | CHEMBL3542353 | |
| 0.059 | 0.063 | 0.102 | Calcium channel P-type blocker | 0.102 0.005 CHEMBL3542353 | CHEMBL3542353 | |
| 0.128 | 0.132 | 0.139 | Ca2+-transporting ATPase inhibitor | 0.139 0.076 CHEMBL3526245 0.13 0.123 CHEMBL3542353 | CHEMBL3526245 | |
| 0.023 | 0.029 | 0.026 | Complement factor 1s inhibitor | 0.026 0.017 CHEMBL3526248 | CHEMBL3526248 | |
| 0.013 | 0.021 | 0.049 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.031 0.009 CHEMBL3526247 0.049 0.006 CHEMBL3526248 | CHEMBL3526248 | |
| 0.019 | 0.027 | 0.066 | Sigma 2 receptor antagonist | 0.066 0.007 CHEMBL3542353 | CHEMBL3542353 | |
| 0.018 | 0.026 | 0.199 | Sigma 1 receptor antagonist | 0.199 0.005 CHEMBL3542353 | CHEMBL3542353 | |
| 0.093 | 0.106 | 0.1 | Cell adhesion inhibitor | 0.1 0.09 CHEMBL3526245 | CHEMBL3526245 | |
| 0.093 | 0.106 | 0.122 | Cholinergic antagonist | 0.122 0.072 CHEMBL3542353 | CHEMBL3542353 | |
| 0.091 | 0.105 | 0.12 | Acetylcholine antagonist | 0.12 0.07 CHEMBL3542353 | CHEMBL3542353 | |
| 0.101 | 0.115 | 0.172 | Calcium channel blocker | 0.172 0.043 CHEMBL3542353 | CHEMBL3542353 | |
| 0.107 | 0.127 | 0.28 | Cholinergic | 0.191 0.05 CHEMBL3542353 0.28 0.022 CHEMBL3526248 | CHEMBL3526248 | |
| 0.131 | 0.154 | 0.148 | Succinate dehydrogenase inhibitor | 0.148 0.117 CHEMBL3526248 | CHEMBL3526248 | |
| 0.169 | 0.193 | 0.226 | Hypoxia-inducible factor 1 alpha inhibitor | 0.226 0.122 CHEMBL3526247 0.214 0.136 CHEMBL3526248 | CHEMBL3526247 | |
| 0.025 | 0.052 | 0.942 | Dopamine D5 antagonist | 0.942 0.001 CHEMBL3527031 | CHEMBL3527031 | |
| 0.031 | 0.058 | 0.08 | 5 Hydroxytryptamine 1 agonist | 0.08 0.025 CHEMBL3527031 0.048 0.038 CHEMBL3526248 | CHEMBL3527031 | |
| 0.128 | 0.158 | 0.143 | Potassium channel blocker | 0.143 0.142 CHEMBL3526248 | CHEMBL3526248 | |
| 0.032 | 0.062 | 0.079 | Dopamine transporter inhibitor | 0.079 0.017 CHEMBL3542353 | CHEMBL3542353 | |
| 0.079 | 0.11 | 0.107 | AMP-activated protein kinase stimulant | 0.107 0.061 CHEMBL3526245 | CHEMBL3526245 | |
| 0.053 | 0.085 | 0.084 | Rho-associated kinase I inhibitor | 0.084 0.042 CHEMBL3526248 | CHEMBL3526248 | |
| 0.07 | 0.103 | 0.245 | Chemokine receptor antagonist | 0.245 0.012 CHEMBL3542353 | CHEMBL3542353 | |
| 0.007 | 0.044 | 0.023 | Prostaglandin EP1 antagonist | 0.023 0.012 CHEMBL3526248 | CHEMBL3526248 | |
| 0.033 | 0.069 | 0.047 | Farnesyltransferase inhibitor | 0.047 0.031 CHEMBL3526248 | CHEMBL3526248 | |
| 0.073 | 0.111 | 0.097 | Interleukin 1 beta converting enzyme inhibitor | 0.097 0.061 CHEMBL3526248 | CHEMBL3526248 | |
| 0.053 | 0.093 | 0.212 | CC chemokine receptor antagonist | 0.212 0.01 CHEMBL3542353 | CHEMBL3542353 | |
| 0.037 | 0.077 | 0.443 | Elastase inhibitor | 0.067 0.025 CHEMBL3526246 0.443 0.002 CHEMBL3527031 | CHEMBL3527031 | |
| 0.171 | 0.212 | 0.341 | Vasodilator, peripheral | 0.341 0.078 CHEMBL3542353 | CHEMBL3542353 | |
| 0.065 | 0.107 | 0.086 | HIV-1 integrase (Overall Integration) inhibitor | 0.086 0.069 CHEMBL3542353 | CHEMBL3542353 | |
| 0.087 | 0.128 | 0.215 | Acetylcholinesterase inhibitor | 0.215 0.029 CHEMBL3526248 | CHEMBL3526248 | |
| 0.082 | 0.124 | 0.101 | Glutamate receptor antagonist | 0.101 0.096 CHEMBL3526247 | CHEMBL3526247 | |
| 0.024 | 0.066 | 0.052 | Neurokinin 3 antagonist | 0.052 0.026 CHEMBL3542353 | CHEMBL3542353 | |
| 0.014 | 0.066 | 0.03 | Histone-lysine N-methyltransferase EZH2 inhibitor | 0.03 0.004 CHEMBL3527031 | CHEMBL3527031 | |
| 0.06 | 0.113 | 0.07 | GABA B receptor agonist | 0.07 0.068 CHEMBL3526245 | CHEMBL3526245 | |
| 0.034 | 0.089 | 0.06 | Cannabinoid receptor agonist | 0.06 0.048 CHEMBL3542353 | CHEMBL3542353 | |
| 0.033 | 0.089 | 0.054 | Nicotinic alpha7 receptor agonist | 0.054 0.037 CHEMBL3526248 | CHEMBL3526248 | |
| 0.011 | 0.07 | 0.018 | CXC chemokine 5 receptor antagonist | 0.018 0.011 CHEMBL3542353 | CHEMBL3542353 | |
| 0.139 | 0.202 | 0.158 | MAP kinase kinase 5 inhibitor | 0.158 0.122 CHEMBL3526248 | CHEMBL3526248 | |
| 0.038 | 0.102 | 0.077 | Glucosylceramidase inhibitor | 0.077 0.017 CHEMBL3526245 | CHEMBL3526245 | |
| 0.026 | 0.091 | 0.051 | Thromboxane antagonist | 0.051 0.04 CHEMBL3542353 | CHEMBL3542353 | |
| 0.062 | 0.129 | 0.082 | Uric acid excretion stimulant | 0.082 0.079 CHEMBL3542353 | CHEMBL3542353 | |
| 0.043 | 0.111 | 0.084 | CXC chemokine receptor antagonist | 0.084 0.034 CHEMBL3542353 | CHEMBL3542353 | |
| 0.028 | 0.096 | 0.094 | Potassium channel small-conductance Ca-activated blocker | 0.043 0.034 CHEMBL3526247 0.094 0.007 CHEMBL3526248 | CHEMBL3526248 | |
| 0.091 | 0.161 | 0.129 | Diuretic | 0.129 0.095 CHEMBL3542353 | CHEMBL3542353 | |
| 0.02 | 0.091 | 0.148 | Neurokinin 2 antagonist | 0.148 0.005 CHEMBL3542353 | CHEMBL3542353 | |
| 0.065 | 0.14 | 0.102 | Protein kinase C zeta inhibitor | 0.097 0.054 CHEMBL3526247 0.102 0.048 CHEMBL3526248 | CHEMBL3526248 | |
| 0.134 | 0.214 | 0.281 | 5 Hydroxytryptamine release stimulant | 0.281 0.076 CHEMBL3542353 | CHEMBL3542353 | |
| 0.009 | 0.093 | 0.025 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.025 0.021 CHEMBL3542353 | CHEMBL3542353 | |
| 0.023 | 0.108 | 0.071 | CC chemokine 5 receptor antagonist | 0.071 0.018 CHEMBL3542353 | CHEMBL3542353 | |
| 0.046 | 0.133 | 0.091 | MAP kinase kinase 8 inhibitor | 0.073 0.041 CHEMBL3526247 0.091 0.027 CHEMBL3526248 | CHEMBL3526248 | |
| 0.072 | 0.163 | 0.115 | Calcium channel N-type blocker | 0.115 0.07 CHEMBL3542353 | CHEMBL3542353 | |
| 0.047 | 0.139 | 0.089 | Protein kinase (CK2) inhibitor | 0.089 0.074 CHEMBL3526248 | CHEMBL3526248 | |
| 0.059 | 0.154 | 0.085 | DNA directed RNA polymerase inhibitor | 0.085 0.076 CHEMBL3526248 | CHEMBL3526248 | |
| 0.11 | 0.206 | 0.458 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.458 0.01 CHEMBL3526248 | CHEMBL3526248 | |
| 0.025 | 0.124 | 0.047 | Potassium channel (Inward rectifier) blocker | 0.047 0.039 CHEMBL3542353 | CHEMBL3542353 | |
| 0.042 | 0.145 | 0.089 | Potassium channel (Ca-activated) activator | 0.089 0.065 CHEMBL3526248 | CHEMBL3526248 | |
| 0.135 | 0.24 | 0.169 | RNA-directed DNA polymerase inhibitor | 0.169 0.154 CHEMBL3526245 | CHEMBL3526245 | |
| 0.067 | 0.187 | 0.372 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.13 0.077 CHEMBL3526247 0.372 0.008 CHEMBL3526248 | CHEMBL3526248 | |
| 0.042 | 0.163 | 0.213 | Butyrylcholinesterase inhibitor | 0.213 0.019 CHEMBL3526248 | CHEMBL3526248 | |
| 0.082 | 0.207 | 0.131 | Hexokinase inhibitor | 0.122 0.115 CHEMBL3526245 0.131 0.102 CHEMBL3526248 | CHEMBL3526248 | |
| 0.094 | 0.22 | 0.135 | Interferon gamma antagonist | 0.135 0.101 CHEMBL3526245 | CHEMBL3526245 | |
| 0.06 | 0.188 | 0.124 | Calcium channel (voltage-sensitive) blocker | 0.124 0.051 CHEMBL3542353 | CHEMBL3542353 | |
| 0.025 | 0.156 | 0.109 | 5 Hydroxytryptamine 1F antagonist | 0.109 0.027 CHEMBL3526248 | CHEMBL3526248 | |
| 0.042 | 0.178 | 0.097 | Protein kinase (CK2) alpha inhibitor | 0.097 0.079 CHEMBL3526248 | CHEMBL3526248 | |
| 0.118 | 0.256 | 0.159 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.159 0.128 CHEMBL3526245 | CHEMBL3526245 | |
| 0.038 | 0.177 | 0.065 | HIV-1 integrase inhibitor | 0.065 0.056 CHEMBL3526248 | CHEMBL3526248 | |
| 0.031 | 0.18 | 0.07 | MAP3K7 inhibitor | 0.07 0.055 CHEMBL3526248 | CHEMBL3526248 | |
| 0.041 | 0.191 | 0.083 | Pim-1 kinase inhibitor | 0.083 0.077 CHEMBL3526248 | CHEMBL3526248 | |
| 0.023 | 0.176 | 0.065 | NMDA 2B receptor antagonist | 0.051 0.041 CHEMBL3526247 0.065 0.028 CHEMBL3526248 | CHEMBL3526248 | |
| 0.035 | 0.19 | 0.077 | Calcium channel L-type blocker | 0.077 0.042 CHEMBL3542353 | CHEMBL3542353 | |
| 0.011 | 0.17 | 0.041 | Geranyltranstransferase inhibitor | 0.041 0.035 CHEMBL3526248 | CHEMBL3526248 | |
| 0.054 | 0.226 | 0.428 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.428 0.013 CHEMBL3526248 | CHEMBL3526248 | |
| 0.07 | 0.249 | 0.184 | LIM domain kinase 1 inhibitor | 0.184 0.071 CHEMBL3526248 | CHEMBL3526248 | |
| 0.06 | 0.249 | 0.252 | Protein kinase (CK1) gamma 1 inhibitor | 0.252 0.028 CHEMBL3526248 | CHEMBL3526248 | |
| 0.021 | 0.23 | 0.061 | Check point kinase 1 inhibitor | 0.061 0.058 CHEMBL3526248 | CHEMBL3526248 | |
| 0.025 | 0.246 | 0.112 | Potassium channel (Ca-activated) blocker | 0.112 0.007 CHEMBL3526248 | CHEMBL3526248 | |
| 0.013 | 0.235 | 0.085 | Neurokinin antagonist | 0.085 0.015 CHEMBL3542353 | CHEMBL3542353 | |
| 0.007 | 0.232 | 0.079 | Protocollagen prolyl hydroxylase inhibitor | 0.079 0.005 CHEMBL3542353 | CHEMBL3542353 | |
| 0.099 | 0.326 | 0.219 | Gastrin inhibitor | 0.219 0.121 CHEMBL3542353 | CHEMBL3542353 | |
| 0.034 | 0.261 | 0.084 | Viral attachment inhibitor | 0.084 0.041 CHEMBL3542353 | CHEMBL3542353 | |
| 0.076 | 0.309 | 0.42 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.235 0.069 CHEMBL3526247 0.42 0.011 CHEMBL3526248 | CHEMBL3526248 | |
| 0.032 | 0.265 | 0.096 | MAP kinase 8 inhibitor | 0.096 0.064 CHEMBL3526248 | CHEMBL3526248 | |
| 0.113 | 0.37 | 0.215 | Antibacterial | 0.215 0.212 CHEMBL3526245 | CHEMBL3526245 | |
| 0.066 | 0.331 | 0.396 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.139 0.123 CHEMBL3526247 0.396 0.018 CHEMBL3526248 | CHEMBL3526248 | |
| 0.063 | 0.329 | 0.172 | Polo-like kinase-3 inhibitor | 0.172 0.064 CHEMBL3526248 | CHEMBL3526248 | |
| 0.003 | 0.286 | 0.053 | Estrogen receptor alpha agonist | 0.053 0.017 CHEMBL3542353 | CHEMBL3542353 | |
| 0.028 | 0.316 | 0.147 | Vascular endothelial growth factor 3 antagonist | 0.147 0.068 CHEMBL3526248 | CHEMBL3526248 | |
| 0.012 | 0.304 | 0.037 | Purinergic P2Y2 antagonist | 0.037 0.019 CHEMBL3526248 | CHEMBL3526248 | |
| 0.009 | 0.305 | 0.045 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.045 0.035 CHEMBL3542353 | CHEMBL3542353 | |
| 0.09 | 0.389 | 0.246 | Nootropic | 0.246 0.111 CHEMBL3542353 | CHEMBL3542353 | |
| 0.029 | 0.338 | 0.166 | Protein kinase (CK1) gamma inhibitor | 0.166 0.059 CHEMBL3526248 | CHEMBL3526248 | |
| 0.031 | 0.352 | 0.154 | Protein kinase (CK1) gamma 2 inhibitor | 0.154 0.047 CHEMBL3526248 | CHEMBL3526248 | |
| 0.033 | 0.358 | 0.24 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.181 0.052 CHEMBL3526247 0.24 0.028 CHEMBL3526248 | CHEMBL3526248 | |
| 0.005 | 0.334 | 0.042 | Substance P antagonist | 0.042 0.024 CHEMBL3542353 | CHEMBL3542353 | |
| 0.078 | 0.415 | 0.194 | MAP-kinase-activated kinase 5 inhibitor | 0.194 0.111 CHEMBL3526247 0.168 0.152 CHEMBL3526248 | CHEMBL3526247 | |
| 0.021 | 0.371 | 0.116 | Vascular endothelial growth factor 1 antagonist | 0.116 0.057 CHEMBL3526248 | CHEMBL3526248 | |
| 0.018 | 0.37 | 0.127 | Protein kinase (CK1) inhibitor | 0.127 0.086 CHEMBL3526248 | CHEMBL3526248 | |
| 0.018 | 0.377 | 0.106 | Protein-tyrosine kinase Lyn inhibitor | 0.106 0.096 CHEMBL3526248 | CHEMBL3526248 | |
| 0.049 | 0.418 | 0.718 | Tumour necrosis factor alpha release inhibitor | 0.718 0.005 CHEMBL3526245 0.275 0.063 CHEMBL3527031 | CHEMBL3526245 | |
| 0.023 | 0.399 | 0.139 | CDC-like kinase 4 inhibitor | 0.139 0.109 CHEMBL3526248 | CHEMBL3526248 | |
| 0.115 | 0.495 | 0.404 | MAP kinase kinase 6 inhibitor | 0.404 0.056 CHEMBL3526248 | CHEMBL3526248 | |
| 0.076 | 0.463 | 0.359 | Toll-Like receptor 7 agonist | 0.359 0.077 CHEMBL3542353 | CHEMBL3542353 | |
| 0.072 | 0.472 | 0.343 | Toll-Like receptor agonist | 0.343 0.086 CHEMBL3542353 | CHEMBL3542353 | |
| 0.011 | 0.421 | 0.051 | Potassium channel Kv1.5 blocker | 0.051 0.048 CHEMBL3526248 | CHEMBL3526248 | |
| 0.026 | 0.451 | 0.147 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.147 0.097 CHEMBL3526248 | CHEMBL3526248 | |
| 0.029 | 0.455 | 0.172 | Death-associated protein kinase 3 inhibitor | 0.172 0.094 CHEMBL3526248 | CHEMBL3526248 | |
| 0.111 | 0.542 | 0.284 | MAP kinase kinase 3 inhibitor | 0.284 0.011 CHEMBL3526248 | CHEMBL3526248 | |
| 0.065 | 0.552 | 0.199 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.199 0.158 CHEMBL3526248 | CHEMBL3526248 | |
| 0.008 | 0.569 | 0.238 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.238 0.073 CHEMBL3526248 | CHEMBL3526248 | |
| 0.009 | 0.573 | 0.246 | Dyrk kinase inhibitor | 0.246 0.074 CHEMBL3526248 | CHEMBL3526248 | |
| 0.01 | 0.577 | 0.085 | Protein kinase C delta inhibitor | 0.085 0.07 CHEMBL3526248 | CHEMBL3526248 | |
| 0.011 | 0.628 | 0.094 | Transforming growth factor antagonist | 0.094 0.024 CHEMBL3526248 | CHEMBL3526248 | |
| 0.008 | 0.65 | 0.139 | Myc inhibitor | 0.139 0.005 CHEMBL3526248 | CHEMBL3526248 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |